DENVER, April 24, 2012 /PRNewswire/ -- FusionPharm Inc. (OTC Markets: FSPM), is proud to announce the successful Harvest and sale of its initial crop.
Scott Dittman, CEO of FusionPharm Inc. stated, "We are very excited to announce the successful harvest and sale of our first lettuce crop. We are ready to show the world that the dream of cost effective commercial vertical farming is now a sustainable and profitable reality. Utilizing the patent pending Pharmpod we are able to provide locally grown produce in one third of the time and utilizing eighty percent less water than traditional agricultural farming methods. Partnered with Circle Fresh Farms a Colorado based produce distributer to whom Whole Foods is one of their biggest customers.
Buck Adams Founder/President of Circle Fresh Farms stated, "The collaboration agreement between FusionPharm Inc. and Circle Fresh Farms is a very exciting one. Both companies are now positioned to vastly expand their reach. We at Circle Fresh are looking forward to FusionPharms roll out into full scale production."
ABOUT FusionPharm Inc.
FusionPharm is a grower and distributor of branded, high-quality hydroponic grown produce.
Development and deployment of the patent pending PharmPods advanced hydroponic cultivation systems. Vertically integrated year-round direct supplier to leading natural and whole foods grocers.
Targeting the $26 billion organic food industry as a "local source" producer of lettuce and other leafy greens.
NOTES ABOUT FORWARD-LOOKING STATEMENTS: Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.
SOURCE FusionPharm Inc.